High flow nasal cannula oxygenation in COVID-19 related acute respiratory distress syndrome: a safe way to avoid endotracheal intubation?


Journal

Therapeutic advances in respiratory disease
ISSN: 1753-4666
Titre abrégé: Ther Adv Respir Dis
Pays: England
ID NLM: 101316317

Informations de publication

Date de publication:
Historique:
entrez: 31 5 2021
pubmed: 1 6 2021
medline: 11 6 2021
Statut: ppublish

Résumé

High flow nasal cannula (HFNC) is an alternative therapy for acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19). This study aimed first to describe outcomes of patients suffering from COVID-19-related ARDS treated with HFNC; secondly to evaluate safety of HFNC (patients and healthcare workers) and compare patients according to respiratory outcome. A retrospective cohort was conducted in French general hospital intensive care unit (ICU). Patients were included if receiving HFNC for hypoxemia (saturation pulse oxygen (SpO From 26 February to 30 June 2020, 46 patients of median age 75 (70-79) years were included. In the HFNC-DNIO group ( HFNC seems to be useful for COVID-19-related ARDS and safe for healthcare workers. ARDS severity with PaO

Sections du résumé

BACKGROUNDS
High flow nasal cannula (HFNC) is an alternative therapy for acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19). This study aimed first to describe outcomes of patients suffering from COVID-19-related ARDS treated with HFNC; secondly to evaluate safety of HFNC (patients and healthcare workers) and compare patients according to respiratory outcome.
METHODS
A retrospective cohort was conducted in French general hospital intensive care unit (ICU). Patients were included if receiving HFNC for hypoxemia (saturation pulse oxygen (SpO
RESULTS
From 26 February to 30 June 2020, 46 patients of median age 75 (70-79) years were included. In the HFNC-DNIO group (
CONCLUSIONS
HFNC seems to be useful for COVID-19-related ARDS and safe for healthcare workers. ARDS severity with PaO

Identifiants

pubmed: 34057844
doi: 10.1177/17534666211019555
pmc: PMC8170326
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

17534666211019555

Références

J Gen Intern Med. 2020 May;35(5):1545-1549
pubmed: 32133578
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Ann Intensive Care. 2020 Mar 30;10(1):37
pubmed: 32232685
Lancet. 2020 Mar 21;395(10228):949-950
pubmed: 32151324
JAMA. 2020 Apr 28;323(16):1612-1614
pubmed: 32191259
Eur Respir J. 2019 Apr 11;53(4):
pubmed: 30705129
Int J Surg. 2020 Apr;76:71-76
pubmed: 32112977
Crit Care Med. 1985 Oct;13(10):818-29
pubmed: 3928249
Am J Emerg Med. 2018 Feb;36(2):226-233
pubmed: 28780231
Crit Care Med. 2017 Dec;45(12):1981-1988
pubmed: 28857852
Eur Respir J. 2020 May 14;55(5):
pubmed: 32299867
Intensive Care Med. 1996 Jul;22(7):707-10
pubmed: 8844239
Am J Respir Crit Care Med. 2020 May 15;201(10):1299-1300
pubmed: 32228035
Respir Care. 2015 Feb;60(2):162-9
pubmed: 25371400
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
PLoS One. 2021 Feb 12;16(2):e0246123
pubmed: 33577565
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Intensive Care Med. 2015 Apr;41(4):623-32
pubmed: 25691263
JAMA. 2016 Feb 23;315(8):788-800
pubmed: 26903337
Respiration. 2018;96(4):323-329
pubmed: 29954000
Ann Intern Med. 2020 May 5;172(9):577-582
pubmed: 32150748
Can J Anaesth. 2020 Sep;67(9):1217-1248
pubmed: 32542464
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
Ann Intensive Care. 2020 May 24;10(1):62
pubmed: 32449053
Crit Care Med. 2020 Jun;48(6):e440-e469
pubmed: 32224769
Intensive Care Med. 2019 May;45(5):563-572
pubmed: 30888444
Crit Care Med. 2020 Sep;48(9):e799-e804
pubmed: 32452888
ERJ Open Res. 2021 Jan 25;7(1):
pubmed: 33527076
N Engl J Med. 2015 Jun 4;372(23):2185-96
pubmed: 25981908
Eur Respir J. 2020 Oct 8;56(4):
pubmed: 32859674
J Hosp Infect. 2019 Jan;101(1):84-87
pubmed: 30336170
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
Intensive Care Med. 2020 Apr;46(4):579-582
pubmed: 32103284

Auteurs

Agathe Delbove (A)

Service de réanimation polyvalente, Centre Hospitalier Bretagne Atlantique, 20, boulevard du Général Maurice Guillaudot, Vannes 56 000, France.

Ambroise Foubert (A)

Service de réanimation polyvalente, Centre Hospitalier Bretagne Atlantique, Vannes, France.

François Mateos (F)

Service de réanimation polyvalente, Centre Hospitalier Bretagne Atlantique, Vannes, France.

Tiphaine Guy (T)

Service de pneumologie, Centre Hospitalier Bretagne Atlantique, Vannes, France.

Marie Gousseff (M)

Service de médecine interne, maladie infectieuse et hématologie, Centre Hospitalier Bretagne Atlantique, Vannes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH